$3.85
-0.18-4.47%
In chiusura: Nov 19, 4:00 PM EST
$3.81
-0.045-1.17%
Pre-mercato: 7:21 AM EST
Comments
Loading...
Recursion Pharmaceuticals Rapporto sugli interessi allo scoperto
RXRXNASDAQ
Report sulle vendite allo scoperto
Il short interest su Recursion Pharmaceuticals Inc (NASDAQ:RXRX) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 126.35M a 128.59M. Questo rappresenta il 26.13% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 64.71M azioni scambiate al giorno, ci vorrebbero 1.99 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
128.59M
Vendite allo scoperto %
26.1%
Giorni di copertura
1.99
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
RXRX | Recursion Pharmaceuticals, Inc | 10/31/2025 | 11/11/2025 | 26.13% | 492,040,602 | 128,586,047 | 64,709,381 | 1.99 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/15/2025 | 10/24/2025 | 31.05% | 406,854,783 | 126,348,417 | 69,403,970 | 1.82 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/30/2025 | 10/09/2025 | 32.79% | 406,854,783 | 133,407,394 | 35,928,102 | 3.71 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/15/2025 | 09/24/2025 | 32.45% | 406,854,783 | 132,044,177 | 16,730,338 | 7.89 | |
RXRX | Recursion Pharmaceuticals, Inc | 08/29/2025 | 09/10/2025 | 30.50% | 406,854,783 | 124,079,106 | 16,288,078 | 7.62 | |
RXRX | Recursion Pharmaceuticals, Inc | 08/15/2025 | 08/26/2025 | 30.26% | 403,883,402 | 122,223,405 | 18,598,548 | 6.57 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/31/2025 | 08/11/2025 | 29.10% | 403,883,402 | 117,535,748 | 33,007,194 | 3.56 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/15/2025 | 07/24/2025 | 28.60% | 403,883,402 | 115,527,481 | 30,617,579 | 3.77 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/30/2025 | 07/10/2025 | 29.07% | 403,883,402 | 117,408,745 | 27,422,295 | 4.28 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/13/2025 | 06/25/2025 | 31.87% | 376,801,373 | 120,075,634 | 36,749,679 | 3.27 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/30/2025 | 06/10/2025 | 28.94% | 376,801,373 | 109,034,492 | 19,542,619 | 5.58 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/15/2025 | 05/27/2025 | 27.66% | 376,801,373 | 104,219,046 | 22,023,595 | 4.73 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/30/2025 | 05/09/2025 | 24.71% | 376,801,373 | 93,117,686 | 14,415,360 | 6.46 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/15/2025 | 04/25/2025 | 25.57% | 369,684,676 | 94,515,655 | 30,201,892 | 3.13 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/31/2025 | 04/09/2025 | 23.94% | 369,684,676 | 88,501,554 | 15,553,625 | 5.69 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/14/2025 | 03/25/2025 | 23.38% | 369,684,676 | 86,416,564 | 20,466,609 | 4.22 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/28/2025 | 03/11/2025 | 21.83% | 369,684,676 | 80,716,710 | 37,222,808 | 2.17 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/14/2025 | 02/26/2025 | 21.06% | 358,336,087 | 75,450,107 | 33,427,821 | 2.26 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/31/2025 | 02/11/2025 | 17.79% | 358,336,087 | 63,748,978 | 17,727,159 | 3.6 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/15/2025 | 01/27/2025 | 18.94% | 358,336,087 | 67,857,806 | 15,986,169 | 4.24 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/31/2024 | 01/10/2025 | 20.68% | 356,513,648 | 73,735,739 | 16,275,526 | 4.53 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/13/2024 | 12/24/2024 | 18.82% | 356,513,648 | 67,097,533 | 17,100,772 | 3.92 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/29/2024 | 12/10/2024 | 19.03% | 356,513,648 | 67,845,763 | 12,760,225 | 5.32 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/15/2024 | 11/26/2024 | 18.12% | 356,353,259 | 64,573,303 | 6,991,077 | 9.24 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/31/2024 | 11/11/2024 | 24.56% | 254,214,840 | 62,427,631 | 3,799,526 | 16.43 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/15/2024 | 10/24/2024 | 22.97% | 258,803,877 | 59,436,441 | 4,461,852 | 13.32 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/30/2024 | 10/09/2024 | 30.91% | 202,439,295 | 62,578,756 | 5,425,024 | 11.54 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/13/2024 | 09/24/2024 | 29.22% | 202,439,295 | 59,162,424 | 4,852,523 | 12.19 | |
RXRX | Recursion Pharmaceuticals, Inc | 08/30/2024 | 09/11/2024 | 27.68% | 202,439,295 | 56,030,343 | 4,357,903 | 12.86 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/31/2024 | 08/09/2024 | 24.88% | 202,439,295 | 50,366,647 | 3,844,470 | 13.1 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/15/2024 | 07/24/2024 | 26.18% | 188,412,721 | 49,327,170 | 5,762,041 | 8.56 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/28/2024 | 07/10/2024 | 23.84% | 188,412,721 | 44,919,972 | 9,626,203 | 4.67 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/14/2024 | 06/26/2024 | 28.50% | 157,643,491 | 44,931,836 | 3,773,645 | 11.91 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/31/2024 | 06/11/2024 | 27.68% | 157,643,491 | 43,637,834 | 4,499,180 | 9.7 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/15/2024 | 05/24/2024 | 26.88% | 157,643,491 | 42,368,012 | 5,893,334 | 7.19 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/30/2024 | 05/09/2024 | 25.69% | 157,643,491 | 40,497,913 | 4,247,037 | 9.54 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/15/2024 | 04/24/2024 | 24.58% | 157,477,026 | 38,704,268 | 4,392,347 | 8.81 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/28/2024 | 04/09/2024 | 25.44% | 156,275,453 | 39,761,938 | 5,885,026 | 6.76 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/15/2024 | 03/26/2024 | 27.85% | 156,275,453 | 43,520,191 | 7,080,455 | 6.15 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/29/2024 | 03/11/2024 | 27.40% | 156,275,453 | 42,815,751 | 11,571,921 | 3.7 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/15/2024 | 02/27/2024 | 27.83% | 137,415,977 | 38,240,528 | 5,530,719 | 6.91 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/31/2024 | 02/09/2024 | 27.85% | 137,415,977 | 38,272,534 | 4,993,651 | 7.66 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/12/2024 | 01/24/2024 | 27.72% | 137,415,977 | 38,088,079 | 8,653,427 | 4.4 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/29/2023 | 01/10/2024 | 26.95% | 137,415,977 | 37,036,264 | 4,553,307 | 8.13 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/15/2023 | 12/27/2023 | 26.94% | 137,415,977 | 37,016,053 | 5,263,124 | 7.03 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/30/2023 | 12/11/2023 | 26.14% | 137,415,977 | 35,921,010 | 4,598,000 | 7.81 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/15/2023 | 11/27/2023 | 25.83% | 137,415,977 | 35,495,991 | 5,290,105 | 6.71 |
In cerca di azioni più vendute allo scoperto?